CYPRUMED

CYPRUMED is a drug delivery company developing a platform technology for the non-invasive delivery of biologics, with a focus on oral peptide delivery. Its key activities include oral formulation development, nasal formulation development, formulation prototype production for non-clinical studies, in vitro protease stability assessment, in vitro permeation studies, and in vivo pharmacokinetic studies in rats, pigs, dogs, and non-human primates.